UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A33 antibody-functionalized exosomes for targeted delivery of doxorubicin against colorectal cancer

Nanomedicine, 2018-10, Vol.14 (7), p.1973-1985

2018

Volltextzugriff (PDF)

Co-delivery of autophagy inhibitor ATG7 siRNA and docetaxel for breast cancer treatment

Journal of controlled release, 2017-11, Vol.266, p.272-286

2017

Volltextzugriff (PDF)

Multi-Size Deep Learning Based Preoperative Computed Tomography Signature for Prognosis Prediction of Colorectal Cancer

Frontiers in genetics, 2022-05, Vol.13, p.880093-880093

2022

Volltextzugriff (PDF)

Artificial Intelligence Assisting the Early Detection of Active Pulmonary Tuberculosis From Chest X-Rays: A Population-Based Study

Frontiers in molecular biosciences, 2022-04, Vol.9, p.874475-874475

2022

Volltextzugriff (PDF)

DNA Repair-Related Gene Signature in Predicting Prognosis of Colorectal Cancer Patients

Frontiers in genetics, 2022-04, Vol.13, p.872238-872238

2022

Volltextzugriff (PDF)

Predicting prognosis and immunotherapy response among colorectal cancer patients based on a tumor immune microenvironment-related lncRNA signature

Frontiers in genetics, 2022-09, Vol.13, p.993714-993714

2022

Volltextzugriff (PDF)

Synergistic effect of reduced polypeptide micelle for co-delivery of doxorubicin and TRAIL against drug-resistance in breast cancer

Oncotarget, 2016-09, Vol.7 (38), p.61832-61844

2016

Volltextzugriff (PDF)

Senescence‐based colorectal cancer subtyping reveals distinct molecular characteristics and therapeutic strategies

MedComm (2020), 2023-08, Vol.4 (4), p.e333-n/a

2023

Volltextzugriff (PDF)

An immune, stroma, and epithelial–mesenchymal transition‐related signature for predicting recurrence and chemotherapy benefit in stage II–III colorectal cancer

Cancer medicine (Malden, MA), 2023-04, Vol.12 (7), p.8924-8936

2023

Volltextzugriff (PDF)

Deep learning based CT images automatic analysis model for active/non-active pulmonary tuberculosis differential diagnosis

Frontiers in molecular biosciences, 2022-12, Vol.9, p.1086047-1086047

2022

Volltextzugriff (PDF)

Aptamer-mediated delivery of docetaxel to prostate cancer through polymeric nanoparticles for enhancement of antitumor efficacy

European journal of pharmaceutics and biopharmaceutics, 2016-10, Vol.107, p.130-141

2016

Volltextzugriff (PDF)

Aptamer-conjugated multi-walled carbon nanotubes as a new targeted ultrasound contrast agent for the diagnosis of prostate cancer

Journal of nanoparticle research : an interdisciplinary forum for nanoscale science and technology, 2018, Vol.20 (11), p.303-10, Article 303

2018

Volltextzugriff (PDF)

Reducible self-assembling cationic polypeptide-based micelles mediate co-delivery of doxorubicin and microRNA-34a for androgen-independent prostate cancer therapy

Journal of controlled release, 2016-06, Vol.232, p.203-214

2016

Volltextzugriff (PDF)

Su1141 MULTIMODAL FUSION SYSTEM FOR PREDICTING RECURRENCE RISK AND IMMUNOTHERAPY EFFICACY IN COLORECTAL CANCER

Gastroenterology (New York, N.Y. 1943), 2024-05, Vol.166 (5), p.S-671-S-671

2024

Volltextzugriff (PDF)

Mo1263 SENESCENCE-BASED COLORECTAL CANCER SUBTYPING REVEALS DISTINCT MOLECULAT CHARACTERISTICS AND THERAPEUTIC STRATEGIES

Gastroenterology (New York, N.Y. 1943), 2023-05, Vol.164 (6), p.S-805-S-805

2023

Volltextzugriff (PDF)

Co-delivery of the autophagy inhibitor si-Beclin1 and the doxorubicin nano-delivery system for advanced prostate cancer treatment

Journal of biomaterials applications, 2022-02, Vol.36 (7), p.1317-1331

2022

Volltextzugriff (PDF)

Efficacy and Mechanism of a Biomimetic Nanosystem Carrying Doxorubicin and an IDO Inhibitor for Treatment of Advanced Triple-Negative Breast Cancer

International journal of nanomedicine, 2024-01, Vol.19, p.507-526

2024

Volltextzugriff (PDF)

A tumor immune microenvironment-related lncRNA signature for the prognosis and immunotherapeutic sensitivity prediction in colorectal cancer

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.3543-3543

2022

Volltextzugriff (PDF)

Tumour microenvironment-responsive lipoic acid nanoparticles for targeted delivery of docetaxel to lung cancer

Scientific reports, 2016-11, Vol.6 (1), p.36281, Article 36281

2016

Volltextzugriff (PDF)

Functionalized Multi-Walled Carbon Nanotubes for Targeting Delivery of Immunostimulatory CpG Oligonucleotides Against Prostate Cancer

Journal of biomedical nanotechnology, 2018-09, Vol.14 (9), p.1613-1626

2018

Volltextzugriff (PDF)

A model combing an immune-related genes signature and an extracellular matrix-related genes signature in predicting prognosis of left- and right-sided colon cancer

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.3533-3533

2021

Volltextzugriff (PDF)

Codelivery of miR-4638–5p and Docetaxel Based on Redox-Sensitive Polypeptide Micelles as an Improved Strategy for the Treatment of Castration-Resistant Prostate Cancer

Molecular pharmaceutics, 2019-01, Vol.16 (1), p.437-447

2019

Volltextzugriff (PDF)

Deciphering tertiary lymphoid structure heterogeneity reveals prognostic signature and therapeutic potentials for colorectal cancer: a multicenter retrospective cohort study

International journal of surgery (London, England), 2024-09, Vol.110 (9), p.5627-5640

2024

Volltextzugriff (PDF)

Deep learning to identify a gene signature associated with molecular subtypes that predicts prognosis in colorectal cancer

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.e15520-e15520

2021

Volltextzugriff (PDF)

Identifying an immune-related gene-pair for prognosis prediction of metastatic colorectal cancer

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.e15565-e15565

2021

Volltextzugriff (PDF)

1 – 25 von 39

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(31)
Mit Volltextzugriff
(36)

Publikationsform

Artikel
(39)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

A33 antibody-functionalized exosomes for targeted delivery of doxorubicin against colorectal cancer

Co-delivery of autophagy inhibitor ATG7 siRNA and docetaxel for breast cancer treatment

Multi-Size Deep Learning Based Preoperative Computed Tomography Signature for Prognosis Prediction of Colorectal Cancer

Artificial Intelligence Assisting the Early Detection of Active Pulmonary Tuberculosis From Chest X-Rays: A Population-Based Study

DNA Repair-Related Gene Signature in Predicting Prognosis of Colorectal Cancer Patients

Predicting prognosis and immunotherapy response among colorectal cancer patients based on a tumor immune microenvironment-related lncRNA signature

Synergistic effect of reduced polypeptide micelle for co-delivery of doxorubicin and TRAIL against drug-resistance in breast cancer

Senescence‐based colorectal cancer subtyping reveals distinct molecular characteristics and therapeutic strategies

An immune, stroma, and epithelial–mesenchymal transition‐related signature for predicting recurrence and chemotherapy benefit in stage II–III colorectal cancer

Deep learning based CT images automatic analysis model for active/non-active pulmonary tuberculosis differential diagnosis

Aptamer-mediated delivery of docetaxel to prostate cancer through polymeric nanoparticles for enhancement of antitumor efficacy

Aptamer-conjugated multi-walled carbon nanotubes as a new targeted ultrasound contrast agent for the diagnosis of prostate cancer

Reducible self-assembling cationic polypeptide-based micelles mediate co-delivery of doxorubicin and microRNA-34a for androgen-independent prostate cancer therapy

Su1141 MULTIMODAL FUSION SYSTEM FOR PREDICTING RECURRENCE RISK AND IMMUNOTHERAPY EFFICACY IN COLORECTAL CANCER

Mo1263 SENESCENCE-BASED COLORECTAL CANCER SUBTYPING REVEALS DISTINCT MOLECULAT CHARACTERISTICS AND THERAPEUTIC STRATEGIES

Co-delivery of the autophagy inhibitor si-Beclin1 and the doxorubicin nano-delivery system for advanced prostate cancer treatment

Efficacy and Mechanism of a Biomimetic Nanosystem Carrying Doxorubicin and an IDO Inhibitor for Treatment of Advanced Triple-Negative Breast Cancer

A tumor immune microenvironment-related lncRNA signature for the prognosis and immunotherapeutic sensitivity prediction in colorectal cancer

Tumour microenvironment-responsive lipoic acid nanoparticles for targeted delivery of docetaxel to lung cancer

Functionalized Multi-Walled Carbon Nanotubes for Targeting Delivery of Immunostimulatory CpG Oligonucleotides Against Prostate Cancer

A model combing an immune-related genes signature and an extracellular matrix-related genes signature in predicting prognosis of left- and right-sided colon cancer

Codelivery of miR-4638–5p and Docetaxel Based on Redox-Sensitive Polypeptide Micelles as an Improved Strategy for the Treatment of Castration-Resistant Prostate Cancer

Deciphering tertiary lymphoid structure heterogeneity reveals prognostic signature and therapeutic potentials for colorectal cancer: a multicenter retrospective cohort study

Deep learning to identify a gene signature associated with molecular subtypes that predicts prognosis in colorectal cancer

Identifying an immune-related gene-pair for prognosis prediction of metastatic colorectal cancer

Suchergebnisse filtern